Navigation Links
New SIMPONI(TM) Data Show Inhibition of Joint Damage in Patients With Rheumatoid Arthritis and Psoriatic Arthritis
Date:10/19/2009

PHILADELPHIA, Oct. 19 /PRNewswire/ -- Phase 3 data reported for the first time show that once every four week subcutaneous injections of SIMPONI(TM) (golimumab) resulted in significantly greater inhibition of structural damage compared with placebo plus methotrexate in patients with active rheumatoid arthritis (RA) and active psoriatic arthritis (PsA). Radiographic analyses showed that treatment with SIMPONI resulted in a statistically significant reduction in change from baseline in structural damage as measured using the van der Heijde-Sharp (vdH-S) scoring method, an X-ray measure of changes in joint destruction, including joint erosion and joint space narrowing. These one-year data were presented at the 2009 American College of Rheumatology Annual Scientific Meeting.

"These findings show that treatment with golimumab and methotrexate inhibited the progression of joint damage in patients with active rheumatoid arthritis and psoriatic arthritis," said Dr. Paul Emery, head of the Academic Unit of Musculoskeletal Medicine at the University of Leeds and lead study investigator. "These data reveal important new insights into the efficacy of golimumab and its effect in altering the potential destructive nature of RA and PsA."

Rheumatoid Arthritis

At week 52 of the GOlimumab Before Employing methotrexate as the First-line Option in the treatment of Rheumatoid arthritis of Early onset (GO-BEFORE) trial, patients with RA receiving SIMPONI plus methotrexate had significantly less progression of structural damage compared with patients receiving placebo plus methotrexate, as measured using the vdH-S score. With this method, higher scores indicate greater structural damage while lower scores indicate less structural damage. The mean change (+/- standard deviation) from baseline in patients treated with SIMPONI 50 mg plus methotrexate was a 0.74 (+/- 5.23) score compa
'/>"/>

SOURCE Centocor Ortho Biotech Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. New SIMPONI(TM) Data Show Long-Term Efficacy in Treatment of Rheumatoid Arthritis
2. Health Canada Approves SIMPONI(TM) (golimumab) for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
3. South Florida Technology Alliance and BioFlorida Joint-Event Draws Big Names and Big Crowd
4. Nanosyn, Inc. and PCAS Announce the Signing of a Joint-Venture Agreement to Operate PCAS-NANOSYN, LLC
5. ClinfoSource and California State University, East Bay Jointly Launch On-Line Certificate Program in Clinical Research
6. Fenwal and Golden Meditech Agree to Form Joint Venture in China for Blood Collection and Transfusion Technologies
7. BP and Martek Biosciences Enter Joint Development Agreement to Deliver Advanced Biodiesels
8. BP and Martek Biosciences Enter a Joint Development Agreement to Deliver Advanced Biodiesels
9. NIH funds support UAB joint replacement research
10. Health Robotics Expands and Diversifies Global Channel Strategies With Joint-Ventures & Direct Operations
11. Cadila Pharmaceuticals Launches Joint Venture With Novavax in India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2010)... off from NASA’s Kennedy Space Center this morning, carrying on ... company created to use microgravity to develop the foundation of ... ... 8, 2010 -- Space Shuttle Endeavor lifted off from NASA’s ... scientific payload for Astrogenetix, a commercial biotech company created to ...
(Date:2/8/2010)... ORLEANS , Feb. 8 Corgenix ... and marketer of diagnostic test kits, and Tulane ... collaborative effort to combat viral hemorrhagic fever (VHF), an ... in contract revenue for Corgenix over the life of ... (NIH) has awarded a five-year contract totaling $15,224,927 ...
(Date:2/8/2010)... announced today that it has been selected by Invida Group, ... Pacific, to develop and execute its corporate communications and public ... ... (Vocus) February 8, 2010 -- LaVoie Group , a ... been selected by Invida Group , the leading provider ...
(Date:2/6/2010)... at Queen,s University Belfast are developing new sensors to ... in the fight against the threat of terrorist attacks. ... ,swipe, an individual or crime scene to gather a ... that can detect the presence of chemicals within seconds. ... in response to terrorist threats. , The scanning ...
Breaking Biology Technology:Astrogenetix Continues MRSA Vaccine Development Onboard Endeavor 2Astrogenetix Continues MRSA Vaccine Development Onboard Endeavor 3Corgenix and Tulane Announce Award of Additional NIH Contract to Expand Lassa Fever Research Towards Development of Vaccines and Improved Therapeutic Agents 2Corgenix and Tulane Announce Award of Additional NIH Contract to Expand Lassa Fever Research Towards Development of Vaccines and Improved Therapeutic Agents 3Corgenix and Tulane Announce Award of Additional NIH Contract to Expand Lassa Fever Research Towards Development of Vaccines and Improved Therapeutic Agents 4Corgenix and Tulane Announce Award of Additional NIH Contract to Expand Lassa Fever Research Towards Development of Vaccines and Improved Therapeutic Agents 5Corgenix and Tulane Announce Award of Additional NIH Contract to Expand Lassa Fever Research Towards Development of Vaccines and Improved Therapeutic Agents 6Corgenix and Tulane Announce Award of Additional NIH Contract to Expand Lassa Fever Research Towards Development of Vaccines and Improved Therapeutic Agents 7Invida Selects LaVoie Group as Public Relations Agency of Record 2Invida Selects LaVoie Group as Public Relations Agency of Record 3New technology detects chemical weapons in seconds 2
... enough e-mail to suggest that I was largely misunderstood when ... reader stated, the idea of getting independence from technology is ... but Im chalking that up to hyperbolic use of a ... technology. That genie just wont go back in the bottle ...
... The typical weekend bicycle rider might think nothing of what ... professionals of the cycling world, it's serious business involving complex ... of Waterloo, Wis., operates under tremendous pressure to get ... Armstrong as he seeks a seventh consecutive victory in his ...
... roundup of stock market results for major indices and the U.S. ... quarter, it was pretty dismal for the major indices: , , ... percent , Nasdaq Biotech down 16% percent , Amex Biotech down ... see below, the results for the first six months of 2005 ...
Other Biology Technology:Lamenting the loss of leisure 2Lamenting the loss of leisure 3A high-tech Trek at the Tour de France 2A high-tech Trek at the Tour de France 3Midwest large cap life sciences mostly outperform market 2Midwest large cap life sciences mostly outperform market 3
(Date:2/8/2010)... offers a wealth of data about how cells respond ... systems is a daunting challenge. In a study ... ), researchers have developed a novel method of interpreting ... biological networks, offering a glimpse into the future of ... been peering through a microscope at cells as they ...
(Date:2/8/2010)... residue from tobacco smoke that clings to virtually ... extinguished, reacts with the common indoor air pollutant ... potential health hazard was revealed in a multi-institutional ... National Laboratory (Berkeley Lab). , "The burning of ... vapor that adsorbs strongly onto indoor surfaces, such ...
(Date:2/8/2010)... age is linked to a significantly elevated risk of ... age, according to an exhaustive study of all births ... System researchers. Advanced paternal age is associated with elevated ... the mother is under 30, the study found. , ... journal Autism Research, the study, "Independent and ...
Breaking Biology News(10 mins):Method of the future uses single-cell imaging to identify gene interactions 2Study reveals new details on the dangers of third-hand smoke 2Study reveals new details on the dangers of third-hand smoke 3Study reveals new details on the dangers of third-hand smoke 4UC Davis study confirms link between advanced maternal age and autism 2UC Davis study confirms link between advanced maternal age and autism 3UC Davis study confirms link between advanced maternal age and autism 4Music makes you smarter 60063 1Sperm May Play Role in Transmission of HIV 60062 1Waste in the U S Healthcare System Pegged at 24700 Billion in Report From Thomson Reuters 60058 1Waste in the U S Healthcare System Pegged at 24700 Billion in Report From Thomson Reuters 60058 2
... the Union speech President Bush said technology is the best ... Department of Energy Joint Genome Institute (DOE JGI) is directing ... processes that will lead to cheaper and easier to produce ... tools of molecular biology we can generate diagnostic fingerprints, Environmental ...
... anti-aging technologies may extend human lifespans at an unprecedented ... economic challenges, says biologist Shripad Tuljapurkar of Stanford University. ... have major implications for the global community in the ... of Population Studies, will give a talk Feb. 17 ...
... natural selection at the single-gene level have a powerful ... researcher in molecular and computational biology in the USC ... that sought to replace the standard neutral model, a ... statistical method based on hard genomic data. , The ...
Other Biology News:Environmental metagenomics diagnosing extreme environments, tapping opportunities for clean energy 2World faces challenge as life expectancies lengthen, scientist says 2World faces challenge as life expectancies lengthen, scientist says 3World faces challenge as life expectancies lengthen, scientist says 4Natural selection at single gene demonstrated 2
Rabbit polyclonal to Kallikrein 1 ( Abpromise for all tested applications). Antigen: Full length native kallikrein from tissue (Human) Entrez Gene ID: 3816 Swiss Protein ID: P06870...
Biotin d anti-mouse Tim-1...
... protein. The epitope is specific for ... any other known protein.,SPECIES REACTIVITIES: ... rabbit, bovine, porcine and guinea pig. ... and mouse (17/19 residues) and chick ...
Mouse monoclonal [J53] to Thyroid Hormone Receptor beta 1 ( Abpromise for all tested applications). entrezGeneID: 7068 SwissProtID: P10828...
Biology Products: